Concepedia

Publication | Open Access

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

DOIFull Paper Access

165

Citations

17

References

2013

Year

R. Willemze, Stefan Suciu, Giovanna Meloni, Boris Labar, Jean-Pierre Marie, Constantijn J.M. Halkes, Petra Muus, Martin Mistrík, Sergio Amadori, Giorgina Specchia,
Journal of Clinical Oncology

Abstract

HD cytarabine produces higher remission and survival rates than SD cytarabine, especially in patients younger than age 46 years.

References

YearCitations

Page 1